CO6280534A2 - Sales antibacteriales - Google Patents

Sales antibacteriales

Info

Publication number
CO6280534A2
CO6280534A2 CO10148308A CO10148308A CO6280534A2 CO 6280534 A2 CO6280534 A2 CO 6280534A2 CO 10148308 A CO10148308 A CO 10148308A CO 10148308 A CO10148308 A CO 10148308A CO 6280534 A2 CO6280534 A2 CO 6280534A2
Authority
CO
Colombia
Prior art keywords
salts
treatment
hrv
relates
picornavirus
Prior art date
Application number
CO10148308A
Other languages
English (en)
Spanish (es)
Inventor
Jane Ryan
Margaret Anne Butt
Original Assignee
Biota Scient Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scient Management filed Critical Biota Scient Management
Publication of CO6280534A2 publication Critical patent/CO6280534A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
CO10148308A 2008-05-27 2010-11-25 Sales antibacteriales CO6280534A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5634108P 2008-05-27 2008-05-27

Publications (1)

Publication Number Publication Date
CO6280534A2 true CO6280534A2 (es) 2011-05-20

Family

ID=41376478

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10148308A CO6280534A2 (es) 2008-05-27 2010-11-25 Sales antibacteriales

Country Status (14)

Country Link
US (2) US8580791B2 (enExample)
EP (1) EP2297141B1 (enExample)
JP (1) JP5469662B2 (enExample)
KR (1) KR20110019759A (enExample)
CN (1) CN102046621B (enExample)
AU (1) AU2009253738B2 (enExample)
BR (1) BRPI0912038A2 (enExample)
CA (1) CA2725618C (enExample)
CO (1) CO6280534A2 (enExample)
EA (1) EA020455B1 (enExample)
MX (1) MX2010013019A (enExample)
NZ (1) NZ590286A (enExample)
WO (1) WO2009143571A1 (enExample)
ZA (1) ZA201009284B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG184430A1 (en) 2010-04-15 2012-11-29 Biota Scient Management Compound for treatment of respiratory condition or disease
EP2585067B1 (en) * 2010-06-25 2017-08-09 Biota Scientific Management Pty Ltd Compound for the treatment of enteroviruses
CN102617462B (zh) * 2012-02-28 2014-02-12 南京大学 特异性抑制肌肉微小核糖核酸的化合物及其合成方法和应用
BR112016029942A2 (pt) * 2014-06-20 2017-08-22 Aviragen Therapeutics Inc composto, forma de base livre cristalina anidra, composição farmacêutica, método para fabricação de uma forma de base livre cristalina, método de tratamento de uma infecção viral, método de tratar, aliviar, prevenir ou reduzir os sintomas ou exacerbações de asma ou doença pulmonar obstrutiva crônica e método de tratamento de doença mão, pé e boca
CA3216679A1 (en) * 2021-05-05 2022-11-10 George R. Painter Nucleotide and nucleoside therapeutic compositions, combinations and uses related thereto
WO2024192151A2 (en) * 2023-03-13 2024-09-19 Altesa BioSciences, Inc. Method of dosing vapendavir to treat enterovirus infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170387B (it) 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB2162522B (en) 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB9026998D0 (en) 1990-12-12 1991-01-30 Glaxo Group Ltd Medicaments
US5514778A (en) * 1993-07-01 1996-05-07 Eli Lilly And Company Anti-picornaviral agents
US5545653A (en) * 1995-06-07 1996-08-13 Eli Lilly And Company Anti-viral compounds
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds
AU6031898A (en) * 1997-01-22 1998-08-07 Eli Lilly And Company Anti-viral compounds
EP1001767A4 (en) * 1997-06-04 2001-07-04 Lilly Co Eli ANTIVIRAL CONNECTIONS
US6358971B1 (en) * 1998-05-20 2002-03-19 Eli Lilly And Company Anti-viral compounds
TR200003414T2 (tr) * 1998-05-20 2001-03-21 Eli Lilly And Company Anti-viral terkipler
AUPR213700A0 (en) * 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents

Also Published As

Publication number Publication date
WO2009143571A1 (en) 2009-12-03
EP2297141A1 (en) 2011-03-23
US20140179710A1 (en) 2014-06-26
ZA201009284B (en) 2012-06-27
AU2009253738A1 (en) 2009-12-03
CA2725618C (en) 2016-04-12
EA201001835A1 (ru) 2011-06-30
CA2725618A1 (en) 2009-12-03
JP2011520991A (ja) 2011-07-21
EP2297141A4 (en) 2012-04-25
CN102046621A (zh) 2011-05-04
AU2009253738B2 (en) 2012-12-13
CN102046621B (zh) 2014-11-12
MX2010013019A (es) 2011-03-21
BRPI0912038A2 (pt) 2017-06-20
EA020455B1 (ru) 2014-11-28
US9206171B2 (en) 2015-12-08
JP5469662B2 (ja) 2014-04-16
NZ590286A (en) 2011-08-26
KR20110019759A (ko) 2011-02-28
EP2297141B1 (en) 2015-10-21
US20110144118A1 (en) 2011-06-16
US8580791B2 (en) 2013-11-12

Similar Documents

Publication Publication Date Title
ECSP17084267A (es) Pirazolo[1,5—a]pirimidinas como agentes antivirales
CR11196A (es) Compuestos quimicos
CL2013000727A1 (es) Compuestos derivados de nucleosidos de imidazo[1,2-f][1,2,4]triazinilo; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion por virus flaviviridae, particularmente infecciones por el virus de la hepatitis c.
ECSP14013315A (es) Inhibidores de aplicación viral
UY32793A (es) Compuestos inhibidores de los virus flaviviridae, composición farmacéutica que los contiene y sus usos
ECSP11011389A (es) Compuestos orgánicos y sus usos
DOP2013000277A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina
CR11310A (es) Espiro-Pirrolidinas y su uso contra infeccion por el virus de Hepatitis C (HCV) y por el virus de Inmunodeficiencia Humana (VIH)
CL2016000805A1 (es) Nucleósidos sustituidos, nucleótidos y análogos de los mismos.
ECSP14004812A (es) Triazolopiridinas sustituidas
ECSP099319A (es) Analogos de tiofeno para el tratamiento o prevencion de las infecciones por flavivirus
UY33097A (es) DERIVADOS DE (1h-PIRAZOL-5-IL)UREIDOARILO 1,3-DISUSTITUIDOS Y SUS USOS TERAPÉUTICOS
ECSP13013019A (es) Derivados de nucleósidos 2'- sustituidos y métodos de uso de los mismos para el tratamiento de enfermedades virales
CO6660497A2 (es) Derivados del ácido nft-2-ilacético para tratar el sida
CL2013001339A1 (es) Compuestos derivados heterociclicos condensados, con actividad antiviral; composicion farmaceutica que los comprende; y su uso para la prevencion o tratamiento de la infeccion de vih.
CR20160123A (es) Inhibidores de polimerasa hcv
MX2020002151A (es) Compuestos antivirales.
ECSP13012418A (es) Derivados de ácido 2-quinolin-acético como compuestos antivirales para vih
MX346264B (es) Compuestos antivirales.
CL2011000527A1 (es) Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c.
CL2012001959A1 (es) Compuestos derivados del acido tiofeno-2-carboxilico, inhibidores de virus flaviviridae; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral por flaviviridae.
CO6592102A2 (es) Compuestos de sililo triciclicos fusionados y metodos de uso de los mismos para el tratamiento de enfermedades virales
CO6280534A2 (es) Sales antibacteriales
ECSP12012104A (es) Inhibidores de virus flaviviridae
CL2013001141A1 (es) Compuestos derivados de heterociclos condensados, inhibidores del virus de la hepatitis c; composicion farmaceutica que los contiene; y su uso para el tratamiento de la infeccion por el virus de la hepatitis c.

Legal Events

Date Code Title Description
FC Application refused